Compare Agilent Technologies Inc (A) vs YieldMax AMZN Option Income Strategy ETF (AMZY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs YieldMax AMZN Option Income Strategy ETF — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while YieldMax AMZN Option Income Strategy ETF trades at $11.42. The key difference: Agilent Technologies Inc pays a 0.69% dividend while YieldMax AMZN Option Income Strategy ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, YieldMax AMZN Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| A | AMZY | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $157.20 | $15.75 |
52-Week Low | $110.24 | $9.98 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
AMZY trades at $11.54, up 0.87% today, with a bullish technical signal from moving averages but a neutral reading from oscillators. The stock faces critical support at $11 and resistance at $12. Recent news highlights consistent weekly dividend distributions, though analyst reports express concerns over potential net asset value erosion despite the high yield strategy.
The outlook is mixed; the high-yield dividend strategy attracts income investors, but fundamental risks include underperformance versus Amazon and sustainability of payouts. Key risks involve amplified downside exposure and competitive pressures, warranting cautious evaluation for long-term growth-oriented investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About YieldMax AMZN Option Income Strategy ETF
AMZY is an actively managed ETF that seeks to generate monthly income by selling call options on Amazon (AMZN) stock. It aims to provide high yield while maintaining exposure to the price movements of the e-commerce giant.
Read more on AMZY →
